Primary record
(1R,3aS,3bR,7E,9aR,9bS,11aS)-11a-ethyl-1-ethynyl-7-(hydroxyimino)-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-ol
- 库存
- 8,877 克
- 纯度
- 98.3 %
- CAS
- 53016-31-2
化合物标识与属性
- CAS
- 53016-31-2
- PubChem CID
- 9568628
- SMILES
- CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=C/C(=N/O)/CC[C@H]34
- Canonical SMILES
- C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=C/C(=N/O)CC[C@@H]4[C@H]3CC[C@@]21CC
名称与同义词
- Norelgestromin
- norelgestromine
- anti-Norelgestromin
- Norelgestromina
- Ortho Evra
- Evra
- 17-Desacetyl Norgestimate
- Levonorgestrel oxime
- Norplant 3-oxime
- ((E)-Norelgestromin)
- Norelgestromin, (E)-
- 17-Deacetylnorgestimate
- Deacetylnorgestimate
- UM2XKY25DH
- (E)-17-Deacetylnorgestimate
- D-Norgestrel 3-oxime
- UNII-UM2XKY25DH
- 53016-31-2
- Norgestimate EP Impurity C
- 18-Methylnorethindrone oxime
- RefChem:1092581
- 17-Deacetylnorgestimate, (E)-
- Norelgestromin (USP/INN)
- Norgestimate impurity C [EP]
- Norelgestromin [USAN:INN]
- UNII-R0TAY3X631
- C21H29NO2
- Norelgestromin (USAN:INN:BAN)
- Norgestimate metabolite Norelgestromin
- SCHEMBL3163347
- CHEMBL1200807
- DTXCID7026788
- DTXSID9046788
- HY-G0018R
- Norelgestromin [USAN:INN:BAN]
- (3Z)-17-Desacetyl Norgestimate
- CHEBI:135398
- RWJ-10553
- ARD10486
- HY-G0018
- Tox21_112647
- 3046AH
- BDBM50103633
- C21-H29-N-O2
- EBC-26598
- MFCD03695603
- AKOS015917579
- CID9568628
- CS-4097
- FD21125
- BRN 4202099
- NCGC00168787-01
- NCGC00485891-01
- CAS-53016-31-2
- J968.614B
- FT-0665916
- NORGESTIMATE IMPURITY C [EP IMPURITY]
- NS00006288
- 74183-55-4
- 17-Deacetyl norgestimate;17-Deacylnorgestimate
- D05205
- DEACETYLNORGESTIMATE (25 MG) ((E)- AND (Z)-17-DEACETYL NORGESTIMATE MIXTURE)
- E75797
- Norgestimate metabolite Norelgestromin (Standard)
- I14-9730
- BRD-K42504537-001-01-6
- Q15295638
- (3E,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-ol
- (17ALPHA)-13-ETHYL-17-HYDROXY-18,19-DINORPREGN-4-EN-20-YN-3-ONE OXIME
- (3E)-13beta-Ethyl-3-(hydroxyimino)-18,19-dinor-17alpha-pregn-4-en-20-yn-17-ol
- 18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, oxime, (3E,17alpha)-
- (17a)-13-Ethyl-17-hydroxy-18,19-dinorpregn-4-en-20-yn-3-one oxime
- (8R,9S,10R,13S,14S,17R,E)-13-ethyl-17-ethynyl-17-hydroxy-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one oxime
- Deacetylnorgestimate (Mixture of (E)- And (Z)-17-Deacetyl Norgestimate)
- (17R)-17-Hydroxy-13-ethyl-18,19-dinorpregna-4-ene-20-yne-3-one (E)-oxime
- (3E,17R)-13beta-Ethyl-17-hydroxy-18,19-dinorpregna-4-ene-20-yne-3-oneoxime
- (1R,3aS,3bR,7E,9aR,9bS,11aS)-11a-ethyl-1-ethynyl-7-(hydroxyimino)-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-ol
- (3E)-13.BETA.-ETHYL-3-(HYDROXYIMINO)-18,19-DINOR-17.ALPHA.-PREGN-4-EN-20-YN-17-OL
- (8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one oxime
- 18,19-DINORPREGN-4-EN-20-YN-3-ONE, 13-ETHYL-17-HYDROXY-, OXIME, (3E,17.ALPHA.)-
- 74183-54-3